Erectile dysfuntion (ED) drugs -- Viagra, Cialis, Levitra -- are in the news again. It seems that ED drug marketers have retooled their campaigns after another disappointing year for sales in this category overall.

Conventional wisdom regarding the pullback in ED drug advertising says it was a result of PhRMA's new DTC guidelines. However, it appears that the marketers have merely regrouped around two core, inter-related messages.

For more on this, see today's post to Pharma Marketing Blog.

More posts about Viagra/Levitra/Cialis/ED Drug Blog Topics.

| Return to Pharma Marketing Blog Topics |